Lutetium-177 vipivotide tetraxetan in combination for treating PSMA-positive hormone-sensitive metastatic prostate cancer ID6589 Consultation on suggested remit, draft scope and provisional ...
Tislelizumab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer ID6304 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results